Indus Lifecare Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 14 Year, 6 Months
- Last Filing with ROC 31 Mar 2024
- Revenue Growth -0.53%
- Profit Growth 38.86%
- Ebitda 30.69%
- Net Worth 86.60%
- Total Assets 62.15%
About Indus Lifecare Pharmaceuticals
Indus Lifecare Pharmaceuticals Private Limited (ILPPL) is a Private Limited Indian Non-Government Company incorporated in India on 07 July 2010 and has a history of 14 years and six months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shruti Singh and Rishi Singh serve as directors at the Company.
Company Details
-
Location
Delhi, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U85110DL2010PTC205433
-
Company No.
205433
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
07 Jul 2010
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Indus Lifecare Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shruti Singh
|
Director | 23-Apr-2011 | Current |
|
Rishi Singh
|
Director | 26-Mar-2012 | Current |
Financial Performance of Indus Lifecare Pharmaceuticals.
Indus Lifecare Pharmaceuticals Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 0.53% decrease. The company also saw a substantial improvement in profitability, with a 38.86% increase in profit. The company's net worth Soared by an impressive increase of 86.6%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Indus Lifecare Pharmaceuticals?
In 2021, Indus Lifecare Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Saint Gillies Overseas Private LimitedShruti Singh is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Indus Lifecare Pharmaceuticals?
Unlock and access historical data on people associated with Indus Lifecare Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Indus Lifecare Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Indus Lifecare Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
